By NZPA
|
Thursday 10th November 2005 |
Text too small? |
The shares were trading at 19c today, up 4c or 26% from Monday. In response to a query from NZX, Blis chief executive Kelvin Moffatt said he believed the company was complying with the regulations regarding the disclosure of material information.
Moffatt said the company was preparing its interim financial statements, which it expected to be in line with market expectations.
The results will be released in the second half of this month, and will include a progress report on the company's research and development work.
Blis manufacturers a range of products which combat bad breath and also recently launched a powder aimed at infants suffering tonsillitis or middle-ear infection, and a chewing gum specifically for bad breath.
Other research is under way to develop a tooth decay-preventing chewing gum and a deodorant aimed at consumers who cannot use deodorants that contain aluminium.
No comments yet
BLIS Technologies announces a net deficit of $1,856k for the March 2013 financial year
Blis share price spike
Blis to clean up share register, buying small parcels
Blis K12 probiotic to get ruff ruff test in dogs
BLIS Technology forecasts wider 2013 loss, seeks to raise capital